Tomeki

Explore Books on
generic substitution

1-24 of 70 Books

View Generic and innovator drugs By Donald O. Beers
Cover of Generic and innovator drugs by donald o. beers

Generic and innovator drugs

By Donald O. Beers

View Competition in the pharmaceutical industry By Meir Statman
Cover of Competition in the pharmaceutical industry by meir statman

Competition in the pharmaceutical industry

By Meir Statman

View "Man-in-the-plant" revisited, a deceptive drug labeling practice continues By United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations.

"Man-in-the-plant" revisited, a deceptive drug labeling practice continues

"Man-in-the-plant" revisited, a deceptive drug labeling practice continues

By United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations.

View Greater access to generic drugs By Michelle Meadows

Greater access to generic drugs

Greater access to generic drugs

By Michelle Meadows

View FDA ensures equivalence of generic drugs By Jeffrey Yorke

FDA ensures equivalence of generic drugs

FDA ensures equivalence of generic drugs

By Jeffrey Yorke

View Increasing generic drug utilization By United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health

Increasing generic drug utilization

Increasing generic drug utilization

By United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health

View Prescription drugs By Sarah F. Jagger

Prescription drugs

Prescription drugs

By Sarah F. Jagger

View Generic drug entry prior to patent expiration By United States. Federal Trade Commission.
Cover of Generic drug entry prior to patent expiration by united states. federal trade commission.

Generic drug entry prior to patent expiration

By United States. Federal Trade Commission.

View Generic substitution and prescription drug prices By Alison Masson

Generic substitution and prescription drug prices

Generic substitution and prescription drug prices

By Alison Masson

View Generic drugs By Donald O. Beers

Generic drugs

Generic drugs

By Donald O. Beers

View Drug comparison handbook By Reilly, Robert Pharm.D.
Cover of Drug comparison handbook by reilly, robert pharm.d.

Drug comparison handbook

By Reilly, Robert Pharm.D.

View Generic And Innovator Drugs By Aspen Publishers
Cover of Generic And Innovator Drugs by aspen publishers

Generic And Innovator Drugs

By Aspen Publishers

View The future of generic drugs in Ireland By Murphy, Michael.

The future of generic drugs in Ireland

The future of generic drugs in Ireland

By Murphy, Michael.

View Mosby's Drug Consult 2003 By Mosby
Cover of Mosby's Drug Consult 2003 by mosby

Mosby's Drug Consult 2003

By Mosby

View Mosby's Drug Consult 2006 (Mosby's Drug Consult) By Mosby
Cover of Mosby's Drug Consult 2006 (Mosby's Drug Consult) by mosby

Mosby's Drug Consult 2006 (Mosby's Drug Consult)

By Mosby

View The market for Rx-to-OTC switches (A Kalorama Information market intelligence report) By Melissa Hutchison

The market for Rx-to-OTC switches (A Kalorama Information market intelligence report)

The market for Rx-to-OTC switches (A Kalorama Information market intelligence report)

By Melissa Hutchison

View The consumer's guide to generic drugs By Donald L. Sullivan
Cover of The consumer's guide to generic drugs by donald l. sullivan

The consumer's guide to generic drugs

By Donald L. Sullivan

View Pricing, patent loss and the market for pharmaceuticals By Richard G. Frank

Pricing, patent loss and the market for pharmaceuticals

Pricing, patent loss and the market for pharmaceuticals

By Richard G. Frank

View Generic drug enforcement By United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.
Cover of Generic drug enforcement by united states. congress. house. committee on energy and commerce. subcommittee on health and the environment.

Generic drug enforcement

By United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

View The Market for RX-To-OTC Switches (Kalorama Information Market Intelligence Report) By Melissa Elder

The Market for RX-To-OTC Switches (Kalorama Information Market Intelligence Report)

The Market for RX-To-OTC Switches (Kalorama Information Market Intelligence Report)

By Melissa Elder

View Drug pricing By United States. Congress. Senate. Committee on Governmental Affairs.
Cover of Drug pricing by united states. congress. senate. committee on governmental affairs.

Drug pricing

By United States. Congress. Senate. Committee on Governmental Affairs.

View The market for prescription generic drugs (A Kalorama Information market intelligence report) By Mary Anne Crandall

The market for prescription generic drugs (A Kalorama Information market intelligence report)

The market for prescription generic drugs (A Kalorama Information market intelligence report)

By Mary Anne Crandall

View Women's Health By Mary Anne Crandall

Women's Health

Women's Health

By Mary Anne Crandall

View Programs to control prescription drug costs under Medicaid and Medicare could be strengthened By United States. General Accounting Office

Programs to control prescription drug costs under Medicaid and Medicare could be strengthened

Programs to control prescription drug costs under Medicaid and Medicare could be strengthened

By United States. General Accounting Office